Skip to main content
Shu-Ying Liu on Muck Rack

Shu-Ying Liu

As seen in: Wiley Online Library, Journal of Automated Methods and Management in Chemistry, The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Shu-Ying

Contact Shu-Ying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Detrimental but Not Doomed-Glial Activation in Rapid Eye Movement Sleep Behavior Disorder

|
By Shu-Ying Liu, Vesna Sossi
| Wiley Online Library Verified
Editorial Detrimental but Not Doomed—Glial Activation in Rapid Eye Movement Sleep Behavior Disorder Shu-Ying Liu, Corresponding Author Shu-Ying Liu Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China Chinese Institute for Brain Research (CIBR), Beijing, China Correspondence to: Dr. Shu-Ying Liu, Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China; E-mail: liu_shuy@xwhosp.org Search for more papers by this authorVesna Sossi,...
Open in Who Shared Issue with article?

Resveratrol rescues motor and cognitive deficits and neuropathology in A53T α-synuclein mouse model of Parkinson’s disease

|
By Xiao-Lin Yu, Mei Ji, Shu-Ying Liu, Li-fan Zhang
| Royal Society of Chemistry Verified
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by Lewy pathology and progressive loss of dopaminergic neurons in the substantia nigra. Lewy pathology mainly consists of abnormal aggregates of α-synuclein, which play a pivotal role in PD pathophysiology. However, the complexity of PD leads to clinical challenges, and there are still no treatments to halt or slow the neurodegenerative process.
Open in Who Shared Issue with article?

The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study

|
By , Daryl J Wile, Jessie Fu, Shu-Ying Liu
| The Lancet Verified
The SeLECT score is useful to predict post-stroke epilepsy
Open in Who Shared Issue with article?
See all 3 licensed articles (4 Total)